News Industry News Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation June 24, 2019
Presentation SIF 2019 Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable Presenter: Saif Anwaruddin March 30, 2019